Therapeutic Asset Ratings
9,928 results matching 1 filter
91,564
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Fapi-46
Cancer Of Unknown Primary Site
Jonsson Comprehensive Cancer Center
P1
CC
(43)
Fapi-46
Cervical Carcinoma
Jonsson Comprehensive Cancer Center
P1
CC
(43)
Fapi-46
Hematopoietic And Lymphoid Cell Neoplasm
Jonsson Comprehensive Cancer Center
P1
CC
(43)
Fapi-46
Adrenal Gland Cancer
Jonsson Comprehensive Cancer Center
P1
CC
(43)
Fapi-46
Brain Cancer
Jonsson Comprehensive Cancer Center
P1
CC
(43)
Fapi-46
Pleural Cancer
Jonsson Comprehensive Cancer Center
P1
CC
(43)
Fapi-46
Skin Cancer
Jonsson Comprehensive Cancer Center
P1
CC
(43)
Fapi-46
Testicular Cancer
Jonsson Comprehensive Cancer Center
P1
CC
(43)
Fapi-46
Thymus Cancer
Jonsson Comprehensive Cancer Center
P1
CC
(43)
Fapi-46
Metastatic Prostate Carcinoma
Jonsson Comprehensive Cancer Center
P1
CC
(43)
Fapi-46
Neuroendocrine Neoplasm
Jonsson Comprehensive Cancer Center
P1
CC
(43)
Fctx-Cl19-1
Acute Lymphoblastic Leukemia
FamiCordTx
P1
CC
(43)
fd-001
Non-Hodgkin Lymphoma
Chengdu FenDi Pharmaceutical Co., Ltd.
P1
CC
(43)
fda018-adc
Metastatic Neoplasm
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.
P1
CC
(43)
FDOPA
Autonomic Nervous System Disorder
Daniel Claassen
P1
CC
(43)
FDOPA
Pancreatic Insulinoma
Cook Children's Health Care System
P1
CC
(43)
FDOPA
Multiple System Atrophy
Daniel Claassen
P1
CC
(43)
FDOPA
Pure Autonomic Failure
Daniel Claassen
P1
CC
(43)
Felmetatug Vedotin
Adenoid Cystic Carcinoma
Seagen, a wholly owned subsidiary of Pfizer
P1
CC
(43)
Felmetatug Vedotin
Her2-Receptor Negative Breast Cancer
Seagen, a wholly owned subsidiary of Pfizer
P1
CC
(43)
Felmetatug Vedotin
Hormone Receptor-Positive Breast Cancer
Seagen, a wholly owned subsidiary of Pfizer
P1
CC
(43)
Felmetatug Vedotin
Triple-Negative Breast Carcinoma
Seagen, a wholly owned subsidiary of Pfizer
P1
CC
(43)
Fenretinide
Primary Cutaneous T-Cell Non-Hodgkin Lymphoma
SciTech Development, Inc.
P1
CC
(43)
Fenretinide
Nodal T-Follicular Helper Cell Lymphoma, Follicular Type
SciTech Development, Inc.
P1
CC
(43)
Fenretinide
Primary Cutaneous T-Cell Lymphoma
SciTech Development, Inc.
P1
CC
(43)
Showing 2051 to 2075 of 9,928 assets
Previous
Page 83 of 398
Next
